» Good Manufacturing Practice (GMP)

Good Manufacturing Practice (GMP)

1960
Pharmaceutical manufacturing facility demonstrating Good Manufacturing Practice standards.

Good Manufacturing Practice (良好生产规范) is a system of regulations and guidelines ensuring that pharmaceutical products are consistently produced and controlled according to quality standards. It covers all aspects of production, from the starting materials, premises, and equipment to the training and personal hygiene of staff. GMP is designed to minimize the risks involved in any pharmaceutical production.

Good Manufacturing Practice (GMP) represents the minimum standard that a medicines manufacturer must meet in their production processes. The core principle of GMP is that quality cannot be tested into a final product; it must be built into the product during all stages of manufacturing. This proactive approach is critical because failures in quality can have life-threatening consequences. GMP guidelines provide a 框架 for managing production and quality control, often referred to as cGMP, with the ‘c’ standing for ‘current’, emphasizing that the 标准 must be up-to-date with the latest technology and scientific understanding. Key components of GMP include robust quality management systems, stringent control over raw materials, validated manufacturing processes, and comprehensive documentation. Every step, from receiving raw materials to shipping the final product, must be documented in detail. This creates a traceable batch record that can be audited to ensure compliance and investigate any deviations or product defects. Personnel must be properly trained for their specific roles, and facilities must be designed and maintained to prevent contamination, mix-ups, and errors. Equipment must be calibrated, cleaned, and validated to ensure it performs as intended. Adherence to GMP is enforced by national regulatory agencies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, through regular inspections of manufacturing facilities. Failure to comply can result in product recalls, fines, and even facility shutdowns.

UNESCO Nomenclature: 3308
– Pharmacy

类型

Abstract System

Disruption

Substantial

使用方法

Widespread Use

Precursors

  • the 1938 federal food, drug, and cosmetic act in the US, which mandated pre-market safety approval
  • the Thalidomide tragedy of the late 1950s and early 1960s, which highlighted severe gaps in drug regulation and testing
  • advances in industrial 过程控制 and quality management theories from other industries

应用

  • manufacturing of prescription and over-the-counter drugs
  • production of vaccines and biologics
  • manufacturing of medical devices
  • production of active pharmaceutical ingredients (apis)
  • quality control in the food and cosmetics industries

专利:

Potential Innovations Ideas

级别需要会员

您必须是!!等级!!会员才能访问此内容。

立即加入

已经是会员? 在此登录
Related to: GMP, cGMP, quality control, quality assurance, pharmaceutical manufacturing, fda, regulation, drug safety, 验证, batch record.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

迎接新挑战
Mechanical Engineer, Project, Process Engineering or R&D Manager
有效的产品开发

可在短时间内接受新的挑战。
通过 LinkedIn 联系我
Plastic metal electronics integration, Design-to-cost, GMP, Ergonomics, Medium to high-volume devices & consumables, Lean Manufacturing, Regulated industries, CE & FDA, CAD, Solidworks, Lean Sigma Black Belt, medical ISO 13485

我们正在寻找新的赞助商

 

您的公司或机构从事技术、科学或研究吗?
> 给我们发送消息 <

接收所有新文章
免费,无垃圾邮件,电子邮件不分发也不转售

或者您可以免费获得完整会员资格以访问所有受限制的内容>这里<

Historical Context

(if date is unknown or not relevant, e.g. "fluid mechanics", a rounded estimation of its notable emergence is provided)

Related Invention, Innovation & Technical Principles

滚动至顶部

你可能还喜欢